FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948908486> ?p ?o ?g. }

• W2948908486 endingPage "271" @default.
• W2948908486 startingPage "262" @default.
• W2948908486 abstract "In the neoadjuvant WSG‐ADAPT‐TN trial, 12‐week nab‐paclitaxel + carboplatin (nab‐pac/carbo) was highly effective and superior to nab‐paclitaxel + gemcitabine (nab‐pac/gem) in triple‐negative breast cancer regarding pathological complete response (pCR). Predictive markers for deescalated taxane/carbo use in TNBC need to be identified. Patients received 4 × nab‐pac 125 mg/m 2 (plus carbo AUC2 or gem 1,000 mg/m 2 d1,8 q21). Expression of 119 genes and PAM50 scores by nCounter were available in 306/336 pretherapeutic samples. Interim survival analysis was planned after 36 months median follow‐up. Basal‐like (83.3%) compared to other subtypes was positively associated with pCR (38% vs . 20%, p = 0.015), as was lower HER2 score ( p < 0.001). Proliferation biomarkers were positively associated with pCR, that is, PAM50 proliferation, ROR scores (all p < 0.004), higher Ki‐67 (IHC; p < 0.001). For nab‐pac/carbo, expression of immunological (CD8, PD1 and PFDL1) genes and proliferation markers (proliferation and ROR scores, MKI67, CDC20, NUF2, KIF2C, CENPF, EMP3 and TYMS) were positively associated with pCR ( p < 0.05 for all). For nab‐pac/gem, angiogenesis genes were negatively associated with pCR (ANGPTL4: p = 0.05; FGFR4: p = 0.02; VEGFA: p = 0.03). pCR after 12 weeks was strongly associated with favorable outcome (3y event‐free survival: 92% vs . 71%, p < 0.001). In early TNBC, basal‐like subtype, higher Ki‐67 (IHC) and lower HER2 score were, associated with chemosensitivity. Chemoresistance pathways differed between the two taxane based combinations. Combination of proliferation/immune markers and PAM50 subtype could allow patient selection for further deescalated chemotherapy and/or immune treatment approaches." @default.
• W2948908486 created "2019-06-14" @default.
• W2948908486 creator A5012681752 @default.
• W2948908486 creator A5013148496 @default.
• W2948908486 creator A5014363979 @default.
• W2948908486 creator A5016623639 @default.
• W2948908486 creator A5019569585 @default.
• W2948908486 creator A5020142852 @default.
• W2948908486 creator A5022444628 @default.
• W2948908486 creator A5026211073 @default.
• W2948908486 creator A5027231412 @default.
• W2948908486 creator A5031666050 @default.
• W2948908486 creator A5040331693 @default.
• W2948908486 creator A5044665296 @default.
• W2948908486 creator A5053393177 @default.
• W2948908486 creator A5053751196 @default.
• W2948908486 creator A5054650117 @default.
• W2948908486 creator A5081829270 @default.
• W2948908486 creator A5087019685 @default.
• W2948908486 creator A5087224341 @default.
• W2948908486 creator A5088032345 @default.
• W2948908486 creator A5089513581 @default.
• W2948908486 creator A5090984572 @default.
• W2948908486 date "2019-06-19" @default.
• W2948908486 modified "2023-10-12" @default.
• W2948908486 title "Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial" @default.
• W2948908486 cites W1481244595 @default.
• W2948908486 cites W1973116775 @default.
• W2948908486 cites W1987545731 @default.
• W2948908486 cites W2018535074 @default.
• W2948908486 cites W2046016820 @default.
• W2948908486 cites W2086064725 @default.
• W2948908486 cites W2096745115 @default.
• W2948908486 cites W2097255042 @default.
• W2948908486 cites W2101192538 @default.
• W2948908486 cites W2102596641 @default.
• W2948908486 cites W2106292881 @default.
• W2948908486 cites W2112648444 @default.
• W2948908486 cites W2114505219 @default.
• W2948908486 cites W2118605519 @default.
• W2948908486 cites W2125885282 @default.
• W2948908486 cites W2129067399 @default.
• W2948908486 cites W2129643153 @default.
• W2948908486 cites W2132163449 @default.
• W2948908486 cites W2132619562 @default.
• W2948908486 cites W2134539328 @default.
• W2948908486 cites W2139517025 @default.
• W2948908486 cites W2139795964 @default.
• W2948908486 cites W2141414987 @default.
• W2948908486 cites W2142226415 @default.
• W2948908486 cites W2147415463 @default.
• W2948908486 cites W2157706516 @default.
• W2948908486 cites W2159274850 @default.
• W2948908486 cites W2161109798 @default.
• W2948908486 cites W2178133357 @default.
• W2948908486 cites W2208824773 @default.
• W2948908486 cites W2264815585 @default.
• W2948908486 cites W2285220377 @default.
• W2948908486 cites W2303905424 @default.
• W2948908486 cites W2394773016 @default.
• W2948908486 cites W2430731787 @default.
• W2948908486 cites W2434209561 @default.
• W2948908486 cites W2566505805 @default.
• W2948908486 cites W2585697071 @default.
• W2948908486 cites W2591601788 @default.
• W2948908486 cites W2606920283 @default.
• W2948908486 cites W2734897937 @default.
• W2948908486 cites W2771978163 @default.
• W2948908486 cites W2772853465 @default.
• W2948908486 cites W2791778837 @default.
• W2948908486 cites W2794018125 @default.
• W2948908486 cites W2797726290 @default.
• W2948908486 cites W2801956643 @default.
• W2948908486 cites W2803428420 @default.
• W2948908486 cites W2807507329 @default.
• W2948908486 cites W2886991068 @default.
• W2948908486 cites W2903044532 @default.
• W2948908486 cites W2915774478 @default.
• W2948908486 doi "https://doi.org/10.1002/ijc.32488" @default.
• W2948908486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31162838" @default.
• W2948908486 hasPublicationYear "2019" @default.
• W2948908486 type Work @default.
• W2948908486 sameAs 2948908486 @default.
• W2948908486 citedByCount "26" @default.
• W2948908486 countsByYear W29489084862020 @default.
• W2948908486 countsByYear W29489084862021 @default.
• W2948908486 countsByYear W29489084862022 @default.
• W2948908486 countsByYear W29489084862023 @default.
• W2948908486 crossrefType "journal-article" @default.
• W2948908486 hasAuthorship W2948908486A5012681752 @default.
• W2948908486 hasAuthorship W2948908486A5013148496 @default.
• W2948908486 hasAuthorship W2948908486A5014363979 @default.
• W2948908486 hasAuthorship W2948908486A5016623639 @default.
• W2948908486 hasAuthorship W2948908486A5019569585 @default.
• W2948908486 hasAuthorship W2948908486A5020142852 @default.
• W2948908486 hasAuthorship W2948908486A5022444628 @default.
• W2948908486 hasAuthorship W2948908486A5026211073 @default.
• W2948908486 hasAuthorship W2948908486A5027231412 @default.

• next